Insights into Early Systemic Treatment in Atopic Dermatitis: Scientific Facts and Practical Considerations Efstratios VakirlisStamatios GregoriouEleni Sotiriou Commentary Open access 27 February 2024 Pages: 563 - 568
Herpes Zoster Recurrence: A Narrative Review of the Literature Raunak ParikhO’Mareen SpenceIain Kaan Review Open access 28 February 2024 Pages: 569 - 592
Integrating the 40-Gene Expression Profile (40-GEP) Test Improves Metastatic Risk-Stratification Within Clinically Relevant Subgroups of High-Risk Cutaneous Squamous Cell Carcinoma (cSCC) Patients Ashley WysongAlly‐Khan SomaniSarah T. Arron Original Research Open access 01 March 2024 Pages: 593 - 612
Regulation of the Immune Cell Repertoire in Psoriasis Patients Upon Blockade of IL-17A or TNFα Julia TittesJennifer BrellJohannes Stöckl Original Research Open access 08 March 2024 Pages: 613 - 626
Treatment Patterns and Negative Health Outcomes in Palmoplantar Pustulosis Patients in Germany and the US Alvan ChengXinqing DengBoni E. Elewski Original Research Open access 05 March 2024 Pages: 627 - 641
Development and Psychometric Validation of a Patient-Reported Outcome Measure to Assess the Signs and Symptoms of Chronic Hand Eczema: The Hand Eczema Symptom Diary (HESD) Sonja MolinLotte Seiding LarsenMarie L. A. Schuttelaar Original Research Open access 15 March 2024 Pages: 643 - 669
Readability of Patient Electronic Materials for Atopic Dermatitis in 23 Languages: Analysis and Implications for Dermatologists Tomasz SkrzypczakAnna SkrzypczakJacek C. Szepietowski Original Research Open access 24 February 2024 Pages: 671 - 684
Satisfaction with Control of Mild to Moderate Atopic Dermatitis with Ruxolitinib Cream: US Physician and Patient Perspectives Lawrence F. EichenfieldJinan LiuPeter Anderson Original Research Open access 08 March 2024 Pages: 685 - 696
The Real-World Effectiveness and Tolerability of a Soothing Cream Containing the Postbiotic Aquaphilus dolomiae Extract-G2 for Skin Healing Yuling ShiEdward LainAline Stennevin Original Research Open access 07 March 2024 Pages: 697 - 712
The Role of the Gut-Joint Axis in the Care of Psoriatic Arthritis: A Two-Sample Bidirectional Mendelian Randomization Study Yihong GanJingqun LiuYongsheng Fan Original Research Open access 07 March 2024 Pages: 713 - 728
Safety of Secukinumab from 1 Million Patient-Years of Exposure: Experience from Post-Marketing Setting and Clinical Trials Rui SunMercedes BustamanteVictor Dong Original Research Open access 07 March 2024 Pages: 729 - 743
Response Types and Factors Associated with Response Types to Biologic Therapies in Patients with Moderate-to-Severe Plaque Psoriasis from Two Randomized Clinical Trials Alexander EgebergCurdin ConradDiamant Thaçi Original Research Open access 15 March 2024 Pages: 745 - 758
The Need of Differential Diagnosis Between Vulvar Lichen Sclerosus and Autoimmune Dermatoses in Adolescent Girls Agnieszka DulskaJakub BodzionyAgnieszka Drosdzol-Cop Original Research Open access 07 March 2024 Pages: 759 - 766
A Prospective, Monocentric Case-Control Study on Uncontrolled Psoriasis as Independent Risk Factor for a Hypercoagulable State Tom M. HillaryTine VanhoutvinSéverine Vermeire Original Research Open access 07 March 2024 Pages: 767 - 775
Effect of Makeup Use on Depressive Symptoms: An Open, Randomized and Controlled Trial Marcos C. VeçosoSouvenir ZallaVânia R. Leite-Silva Original Research Open access 21 March 2024 Pages: 777 - 791
Improvements in Plaque Psoriasis Associated with Calcipotriol/Betamethasone Aerosol Foam Treatment: A Post Hoc Analysis of Non-interventional Studies and Clinical Experience Sascha GerdesAnna CampanatiElizabeth Lazaridou Brief Report Open access 15 February 2024 Pages: 793 - 804
Botulinum Toxin A and B for Palmoplantar Hyperhidrosis Trond EilertsenBjørn Øivind KvammenØystein Grimstad Brief Report Open access 01 March 2024 Pages: 805 - 811
Successful Treatment of Disseminated Granuloma Annulare with Upadacitinib Axel De GreefGhita BenjellounMarie Baeck Case Report Open access 05 March 2024 Pages: 813 - 817
Letter to the Editor Regarding ‘Matching-Adjusted Indirect Comparison of the Long-Term Efficacy Maintenance and Adverse Event Rates of Lebrikizumab Versus Dupilumab in Moderate-to-Severe Atopic Dermatitis’ Mike BastianNick FreemantlePatricia Guyot Letter Open access 16 February 2024 Pages: 819 - 821
Response to “Letter to the Editor Regarding ‘Matching-Adjusted Indirect Comparison of the Long-Term Efficacy Maintenance and Adverse Event Rates of Lebrikizumab vs. Dupilumab in Moderate to Severe Atopic Dermatitis’” Kim RandJuan Manuel Ramos-GoñiJosé-Carlos Armario-Hita Letter Open access 05 March 2024 Pages: 823 - 827